What is aTyr Pharma's total equity?

aTyr Pharma (ATYR) reported total equity of $57.93M in Q1 2026.

How has aTyr Pharma's total equity changed year-over-year?

aTyr Pharma's total equity decreased by 22.8% year-over-year, from $75.05M to $57.93M.

What is the long-term trend for aTyr Pharma's total equity?

Over 5 years (2020 to 2025), aTyr Pharma's total equity has grown at a 16.3% compound annual growth rate (CAGR), from $31.65M to $67.48M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

aTyr Pharma ATYR Total Equity

Total Equity at other companies

Bristol-Myers SquibbBMY

$20.07B+15.4%

Merck & Co.MRK

$45.88B-5.1%

United TherapeuticsUTHR

$5.9B-13.3%

Design Therapeutics, Inc.DSGN

$218.05M-4.3%

Oric Pharmaceuticals, Inc.ORIC

$415.56M+89.1%

Vor BiopharmaVOR

-$150.42M-328%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's total equity?: aTyr Pharma (ATYR) reported total equity of $57.93M in Q1 2026.
How has aTyr Pharma's total equity changed year-over-year?: aTyr Pharma's total equity decreased by 22.8% year-over-year, from $75.05M to $57.93M.
What is the long-term trend for aTyr Pharma's total equity?: Over 5 years (2020 to 2025), aTyr Pharma's total equity has grown at a 16.3% compound annual growth rate (CAGR), from $31.65M to $67.48M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.